Literature DB >> 27009622

Buprenorphine and the treatment of depression, anxiety, non-suicidal self-injury, and suicidality.

L Sher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27009622     DOI： 10.1111/acps.12577

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  2 in total

Review 1.  Investigational drugs in recent clinical trials for treatment-resistant depression.

Authors:  Ricardo P Garay; Carlos A Zarate; Thomas Charpeaud; Leslie Citrome; Christoph U Correll; Ahcène Hameg; Pierre-Michel Llorca
Journal:  Expert Rev Neurother       Date:  2017-01-29       Impact factor: 4.618

Review 2.  The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review.

Authors:  Gianluca Serafini; Giulia Adavastro; Giovanna Canepa; Domenico De Berardis; Alessandro Valchera; Maurizio Pompili; Henry Nasrallah; Mario Amore
Journal:  Int J Mol Sci       Date:  2018-08-15       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.